Patent · US Expired

Thiazole derivatives as phosphodiesterase IV inhibitors

US7790723B2 · kind B2 · utility

9Cited by

2References

3Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Hans-Michael Eggenweiler · Darmstadt, DE
Michael Wolf · Darmstadt, DE

Key dates

Filing date	Apr 28, 2003
Grant date	Sep 7, 2010
Priority date	—
Expiry date	Dec 2, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Thiazole derivatives of the formula Iin which R1, R2, R3, V, W, X and B are as defined in claim 1, act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.